Mechanisms of Spliceosome Assembly and Splice Site Recognition

剪接体组装和剪接位点识别的机制

基本信息

  • 批准号:
    8996582
  • 负责人:
  • 金额:
    $ 28.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-02-01 至 2020-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): PROJECT SUMMARY RNA splicing-the removal of introns and ligation of exons-is an essential step in eukaryotic gene expression and must occur precisely. Precision depends on accurate recognition of the splice sites within RNAs by a macromolecular machine called the spliceosome. Spliceosomes are assembled at particular locations in transcripts from protein and small nuclear ribonucleoprotein (snRNP) components. In humans, most RNAs are alternatively spliced meaning that the spliceosome can incorporate multiple regulatory signals to control the splicing fate of a given transcript. Many of the key steps in regulating alternative splicing and splicing efficiency occur in the earliest stages of spliceosome assembly. During these steps in yeast, the 5' splice site (SS) and the branchsite (BS) are first recognized by the U1 snRNP and the BBP/Mud2 protein heterodimer, respectively. This forms the so-called commitment complex (CC) that then recruits U2 to form the pre-spliceosome. Pre-spliceosome formation is believed to determine the alternative splicing fate of many transcripts and defects in human CC and pre-spliceosome components are linked to genetic diseases including myelodysplastic syndrome (MDS). The ultimate goals of this project are to understand the pathways by which spliceosomes assemble on RNAs. While the identities of the players in these processes are known, their mechanisms of action remain unclear. Investigation of these events will lead to a better understanding of this fundamental process as well as provide new insights into diseases linked to splicing. Here, we focus on formation of the spliceosomal CC and its transition into the pre-spliceosome. In these experiments, we exploit the unique capabilities of single molecule fluorescence as our primary tool. In Aim 1, we will purify the components of CC and reconstitute its assembly in vitro. A key outcome of Aim 1 is a purified, biochemically characterized system for studying CC formation. This is a necessary step in our long-term objective of biochemically reconstituting spliceosome assembly. In Aim 2, we study the disassembly of single molecules of CC and the formation of pre-spliceosomes using a novel combination of purified components and yeast cell extracts. In Aim 3, we use a variety of approaches to study the binding and conformational dynamics of the Prp5 ATPase during pre- spliceosome formation. Together these experiments will provide much needed new insights into spliceosome assembly and the ways in which it can be regulated.
描述(由申请人提供): 项目摘要RNA剪接-去除内含子和连接外显子-是真核基因表达的关键步骤,必须准确发生。精确度取决于被称为剪接体的大分子机器对RNA中剪接位点的准确识别。剪接体在蛋白质和小核核糖核蛋白(SnRNP)组分的转录本中的特定位置组装。在人类中,大多数RNA是交替剪接的,这意味着剪接体可以整合多种调控信号来控制给定转录本的剪接命运。调控选择性剪接和剪接效率的许多关键步骤发生在剪接体组装的早期阶段。在酵母中的这些步骤中,5‘剪接点(SS)和分支点(BS)分别首先被U1SnRNP和BBP/Mud2蛋白异源二聚体识别。这形成了所谓的承诺复合体(CC),然后招募U2形成预剪接体。剪接体前的形成被认为决定了人类CC中许多转录本和缺陷的选择性剪接命运,剪接体前组分与包括骨髓增生异常综合征(MDS)在内的遗传性疾病有关。这个项目的最终目标是了解剪接体在RNA上组装的途径。虽然这些过程中参与者的身份是已知的,但他们的行动机制仍然不清楚。对这些事件的调查将有助于更好地理解这一基本过程,并为与剪接相关的疾病提供新的见解。在这里,我们集中在剪接体CC的形成和它向剪接体前的过渡。在这些实验中,我们利用单分子荧光的独特能力作为我们的主要工具。在目标1中,我们将纯化CC的成分,并在体外重建其组装。AIM 1的一个关键成果是一个用于研究CC形成的纯化的、生化特征的系统。这是我们生化重建剪接体组装的长期目标中必要的一步。在目标2中,我们使用一种新的纯化成分和酵母细胞提取物的组合来研究CC单分子的分解和预剪接体的形成。在目标3中,我们使用各种方法研究Prp5 ATPase在剪接体前形成过程中的结合和构象动力学。总之,这些实验将为剪接体组装及其调控方式提供亟需的新见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Aaron Andrew Hoskins其他文献

Aaron Andrew Hoskins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Aaron Andrew Hoskins', 18)}}的其他基金

Administrative Supplement: Mechanisms of Spliceosome Assembly and Regulation
行政补充:剪接体组装与调控机制
  • 批准号:
    10169637
  • 财政年份:
    2020
  • 资助金额:
    $ 28.47万
  • 项目类别:
Administrative Supplement: Mechanisms of Spliceosome Assembly and Regulation
行政补充:剪接体组装与调控机制
  • 批准号:
    10378361
  • 财政年份:
    2020
  • 资助金额:
    $ 28.47万
  • 项目类别:
Mechanisms of Spliceosome Assembly and Regulation
剪接体组装和调控机制
  • 批准号:
    10608952
  • 财政年份:
    2020
  • 资助金额:
    $ 28.47万
  • 项目类别:
Mechanisms of Spliceosome Assembly and Regulation
剪接体组装和调控机制
  • 批准号:
    10393514
  • 财政年份:
    2020
  • 资助金额:
    $ 28.47万
  • 项目类别:
Administrative Supplement: Mechanisms of Spliceosome Assembly and Regulation
行政补充:剪接体组装与调控机制
  • 批准号:
    10807767
  • 财政年份:
    2020
  • 资助金额:
    $ 28.47万
  • 项目类别:
Administrative Supplement: Mechanisms of Spliceosome Assembly and Regulation
行政补充:剪接体组装与调控机制
  • 批准号:
    10797871
  • 财政年份:
    2020
  • 资助金额:
    $ 28.47万
  • 项目类别:
Mechanisms of Spliceosome Assembly and Splice Site Selection
剪接体组装和剪接位点选择的机制
  • 批准号:
    8308082
  • 财政年份:
    2008
  • 资助金额:
    $ 28.47万
  • 项目类别:
Mechanisms of Spliceosome Assembly and Splice Site Selection
剪接体组装和剪接位点选择的机制
  • 批准号:
    8325655
  • 财政年份:
    2008
  • 资助金额:
    $ 28.47万
  • 项目类别:
Mechanisms of Spliceosome Assembly and Splice Site Selection
剪接体组装和剪接位点选择的机制
  • 批准号:
    8535781
  • 财政年份:
    2008
  • 资助金额:
    $ 28.47万
  • 项目类别:
Single Molecule Analysis of Spliceosome Catalysis and Fidelity
剪接体催化和保真度的单分子分析
  • 批准号:
    7570401
  • 财政年份:
    2008
  • 资助金额:
    $ 28.47万
  • 项目类别:

相似海外基金

Mechanisms of Splice Site Selection in Health and Disease
健康和疾病中剪接位点选择的机制
  • 批准号:
    10797554
  • 财政年份:
    2023
  • 资助金额:
    $ 28.47万
  • 项目类别:
Quantitative and Predictive Analysis of 5' Splice Site Recognition by U1 snRNP using Massively Parallel Arrays
使用大规模并行阵列对 U1 snRNP 5 剪接位点识别进行定量和预测分析
  • 批准号:
    10460136
  • 财政年份:
    2021
  • 资助金额:
    $ 28.47万
  • 项目类别:
Quantitative and Predictive Analysis of 5' Splice Site Recognition by U1 snRNP using Massively Parallel Arrays
使用大规模并行阵列对 U1 snRNP 5 剪接位点识别进行定量和预测分析
  • 批准号:
    10311645
  • 财政年份:
    2021
  • 资助金额:
    $ 28.47万
  • 项目类别:
Uncovering Mechanisms of 5' Splice Site Fidelity
揭示 5 剪接位点保真度的机制
  • 批准号:
    10532793
  • 财政年份:
    2020
  • 资助金额:
    $ 28.47万
  • 项目类别:
How do RNA-binding proteins control splice site selection?
RNA 结合蛋白如何控制剪接位点选择?
  • 批准号:
    BB/T000627/1
  • 财政年份:
    2020
  • 资助金额:
    $ 28.47万
  • 项目类别:
    Research Grant
Mechanism of Splice Site Recognition by the U2AF/SF1 Protein Complex
U2AF/SF1 蛋白复合物的剪接位点识别机制
  • 批准号:
    553974-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 28.47万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Uncovering Mechanisms of 5' Splice Site Fidelity
揭示 5 剪接位点保真度的机制
  • 批准号:
    10316181
  • 财政年份:
    2020
  • 资助金额:
    $ 28.47万
  • 项目类别:
Mechanisms of Splice Site Selection in Health and Disease
健康和疾病中剪接位点选择的机制
  • 批准号:
    10769989
  • 财政年份:
    2019
  • 资助金额:
    $ 28.47万
  • 项目类别:
Mechanisms of Splice Site Selection in Health and Disease
健康和疾病中剪接位点选择的机制
  • 批准号:
    10808389
  • 财政年份:
    2019
  • 资助金额:
    $ 28.47万
  • 项目类别:
Mechanisms of Splice Site Selection in Health and Disease
健康和疾病中剪接位点选择的机制
  • 批准号:
    10585911
  • 财政年份:
    2019
  • 资助金额:
    $ 28.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了